Lactobacillus rhamnosus GR-1, according to Andrew J Martins and his colleagues, could escalate the expression of G-CSF in healthy individuals but failed to reverse G-CSF reduction in IBD patients, thus exhibited their prophylaxis but not treatment value [27]. The gene discussed is CSF3; the disease is inflammatory bowel disease.